Sequence 2

DRUG8 trials

Sponsors

Janssen Research & Development, LLC, Yuhan Corporation, Samyang Biopharmaceuticals Corporation, University of Colorado, Denver, Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHealthyHyperlipidemiaHypertensionMild Cognitive DisorderNeoplasm MetastasesRespiratoryUpper Limb Spasticity

Phase 1

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

CompletedNCT01273480

Janssen Research & Development, LLCNeoplasm Metastases

Start: 2010-12-31End: 2012-10-31Updated: 2014-11-25

Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

CompletedNCT01332890

Yuhan CorporationHealthy

Start: 2011-04-30End: 2011-08-31Updated: 2014-07-10

Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

CompletedNCT01353404

Samyang Biopharmaceuticals CorporationHyperlipidemia

Start: 2011-06-30End: 2011-08-31Updated: 2012-12-18

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2018-08-31End: 2019-01-15Target: 30Updated: 2018-11-01

A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity

CompletedNCT06584240

JHM BioPharma (Tonghua) Co. , Ltd.Upper Limb Spasticity

Start: 2024-09-14End: 2025-07-23Updated: 2025-09-02

Phase 3

HANDLING USI20 Study: Satisfaction assessment and Good Usage Practice of RS01® versus Handihaler® inhalers in patients with COPD, a randomized comparative multicenter study

Active, not recruitingPACTR202008893896971

OPALIA pharma RECORDATI GroupRespiratory

Start: 2020-07-15Target: 87Updated: 2026-08-03

Unknown Phase

A Pilot Study: Snacking, Willpower and Glucose Availability

CompletedNCT02258477

University of Colorado, DenverWillpower

Start: 2014-10-31End: 2015-02-28Updated: 2016-03-04

Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.

RecruitingNCT04754906

Centre Hospitalier Universitaire DijonMild Cognitive Disorder

Start: 2021-01-25End: 2028-12-31Target: 684Updated: 2025-09-22

Related Papers

Effects of cytochrome P450 inducer and inhibitor coadministration on the pharmacokinetics of trabectedin in patients with advanced or metastatic solid tumors.

Journal of Clinical Oncology2014-05-20